Nursing care of a case of fulminant type 1 diabetes mellitus related to immune checkpoint inhibitor

doi:10.3761/j.issn.0254-1769.2023.24.003

Abstract

Abstract:

The observation and nursing care of a case of fulminant type 1 diabetes mellitus related to immune checkpoint inhibitor were summarized. To improve prognosis of the disease and guarantee patients’ safety，key points of nursing are as following：sufficient early liquid resuscitation to improve renal perfusion；dynamic monitoring and summary of blood glucose changes，implementing a target-oriented blood glucose management program；providing nutritional support；regularly follow-up and health education. After positive rescue and careful nursing，no serious complications occurred；blood glucose was controlled well；nutritional status was improved；the patient was in stable conditions and was discharged. Telephone follow-up of the patient for 3 months showed stable blood glucose and good condition.

Key words: Immune Checkpoint Inhibitor, Fulminant Type 1 Diabetes Mellitus, Oncologic Nursing

摘要：

总结1例免疫检查点抑制剂相关暴发性1型糖尿病患者的护理经验。护理要点：早期充分的液体支持，改善肾灌注；动态监测及总结血糖变化规律，实施目标导向性血糖管理方案；加强营养支持；定期随访与健康教育。经过积极治疗与精心护理，患者病情好转并顺利出院。电话随访3个月，血糖控制平稳，营养状况改善，整体状况良好。

关键词: 免疫检查点抑制剂, 暴发性1型糖尿病, 肿瘤护理

ZHANG Xing, ZENG Lirong, PEI Jia, CHEN Haoying. Nursing care of a case of fulminant type 1 diabetes mellitus related to immune checkpoint inhibitor[J]. Chinese Journal of Nursing, 2023, 58(24): 2964-2966.

张星, 曾莉容, 裴佳, 陈浩莹. 1例免疫检查点抑制剂相关暴发性1型糖尿病患者的护理[J]. 中华护理杂志, 2023, 58(24): 2964-2966.

References 10

[1]	中华医学会内分泌学分会免疫内分泌学组. 免疫检查点抑制剂引起的内分泌系统免疫相关不良反应专家共识(2020)[J]. 中华内分泌代谢杂志, 2021, 37(1):1-16.
	Immune-endocrinology Group, Chinese Society of Endocrinology, Chinese Medical Association. Chinese expert consensus on the immune checkpoint inhibitors-induced endocrine immune-related adverse events(2020)[J]. Chin J Endocrinol Metab, 2021, 37(1):1-16.
[2]	Liu JQ, Zhou HQ, Zhang YX, et al. Reporting of immune checkpoint inhibitor therapy-associated diabetes,2015-2019[J]. Diabetes Care, 2020, 43(7):e79-e80. DOI URL
[3]	杨中策, 董林涛, 潘俐, 等. 中国暴发1型糖尿病患者临床特点的Meta分析[J]. 中国循证医学杂志, 2022, 22(8):891-895.
	Yang ZC, Dong LT, Pan L, et al. Clinical characteristics of Chinese patients with fulminant type 1 diabetes mellitus:a meta-analysis[J]. Chin J Evid Based Med, 2022, 22(8):891-895.
[4]	Imagawa A. Two types of fulminant type 1 diabetes mellitus:immune checkpoint inhibitor-related and conventional[J]. J Diabetes Investig, 2021, 12(6):917-919. DOI URL
[5]	邱俊霖, 罗说明, 殷文凤, 等. PD-1相关性暴发性1型糖尿病的临床与免疫特征[J]. 中南大学学报(医学版), 2023, 48(1):49-58.
	Qiu JL, Luo SM, Yin WF, et al. Clinical and immunological characteristics of PD-1 associated fulminant type 1 diabetes mellitus[J]. J Central South Univ Med Sci, 2023, 48(1):49-58.
[6]	杨稳, 严健如, 罗泰宏, 等. 抗PD-1治疗诱导暴发性1型糖尿病一例报道[J]. 中国糖尿病杂志, 2022, 30(10):783-785.
	Yang W, Yan JR, Luo TH, et al. Fulminant type 1 diabetes mellitus induced by programmed cell death protein 1 inhibitor:a case report[J]. Chin J Diabetes, 2022, 30(10):783-785.
[7]	中华医学会糖尿病学分会, 中国医师协会内分泌代谢科医师分会, 中华医学会内分泌学分会, 等. 中国1型糖尿病诊治指南(2021版)[J]. 中华糖尿病杂志, 2022, 14(11):1143-1250.
	Chinese Diabetes Society,Chinese Endocrinologist Association,Chinese Endocrinology Association, et al. Guidelines for the diagnosis and treatment of type 1 diabetes mellitus in China(2021 edition)[J]. Chin J Diabetes Mellit, 2022, 14(11):1143-1250.
[8]	Clotman K, Janssens K, Specenier P, et al. Programmed cell death-1 inhibitor-induced type 1 diabetes mellitus[J]. J Clin Endocrinol Metab, 2018, 103(9):3144-3154. DOI PMID
[9]	费超男, 段培蓓, 杨玲, 等. 胃癌患者围手术期营养管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(19):2345-2352. DOI URL
	Fei CN, Duan PB, Yang L, et al. Evidence summary of nutri-tional management in patients with gastric cancer during the perioperative period[J]. Chin J Nurs, 2022, 57(19):2345-2352.
[10]	中国医疗保健国际交流促进会营养与代谢管理分会, 中国营养学会临床营养分会, 中华医学会糖尿病学分会, 等. 中国糖尿病医学营养治疗指南(2022版)[J]. 中华糖尿病杂志, 2022, 14(9):881-933.
	Nutrition and Metabolic Management Branch, China Healthcare International Exchange Promotion Associatione, Clinical Nutrition Branch of the Chinese Nutrition Society, et al. Chinese guidelines of medical nutrition therapy in diabetes(2022 edition)[J]. Chin J Diabetes Mellit, 2022, 14(9):881-933.

[1]	ZHU Huidi, ZHANG Meiyun, JIANG Yuehong, LI Beiei, XU Qiaoying. Nursing care of a patient with gastric cancer who developed cytokine release syndrome after the use of immune checkpoint inhibitors [J]. Chinese Journal of Nursing, 2024, 59(4): 469-473.
[2]	LIN Xianping, YANG Lili, GUO Xinli, TIAN Hefeng, YANG Weijie, QIAO Shina, QI Haiou. Design of a storage device for lymph node specimens of gynecological malignant tumors and its application [J]. Chinese Journal of Nursing, 2024, 59(4): 506-509.
[3]	Chinese Nursing Association Oncology Nursing Committee, Shanghai Anti-Cancer Association Tumor Nursing Committee （Writing Committee：YANG Yang, ZHANG Xiaoju, LU Zhenqi, GUO Xiaolu）. Expert consensus on self-management of targeted drug-related skin adverse reactions in cancer patients [J]. Chinese Journal of Nursing, 2024, 59(17): 2095-2099.
[4]	HU Yinyan, ZHAO Linfang, HE Xiaoying, LIU Minjun. Nursing care of a postoperative patient with esophageal cancer complicated by severe immune checkpoint inhibitor-related pneumonia and anastomotic fistula [J]. Chinese Journal of Nursing, 2024, 59(14): 1752-1756.
[5]	LI He, ZHANG Meiyun, YU Sufen, TANG Linna, SHI Xiaolan. Construction and application of an intelligent discharge follow-up information system for patients with cancer pain [J]. Chinese Journal of Nursing, 2024, 59(13): 1562-1567.
[6]	ZHANG Xu, SUN Di, LI Xiaohan, LI Jiaojiao, QIN Nan, LI Heji. Fear of recurrence in cancer patients：a latent profile analysis [J]. Chinese Journal of Nursing, 2023, 58(6): 662-669.
[7]	ZHANG Fengyi, LIU Suting, ZHANG Lili. Research progress on application of patient decision aid in fertility preservation of cancer patients [J]. Chinese Journal of Nursing, 2023, 58(6): 689-694.
[8]	LI Zhen, ZHOU Meng, CHEN Luna, QU Ruijie, CHEN Sinuo, WANG Huiling. Sinicization of the quality of working life questionnaire for cancer survivors and the test of its reliability and validity [J]. Chinese Journal of Nursing, 2023, 58(6): 695-700.
[9]	LI Lijun, DUAN Yinglong, LIU Xiangyu, CHENG Qinqin, XIE Jianfei, Andy SK Cheng. Sinicization of the Cancer Peer Support Scale and the test of its reliability and validity [J]. Chinese Journal of Nursing, 2023, 58(3): 374-379.
[10]	SUN Yue, WANG Zhimin, HU Ying, GE Jingling. Development and application of a follow-up checklist for postoperative patients with cervical cancer [J]. Chinese Journal of Nursing, 2023, 58(24): 2989-2995.
[11]	LIU Zhiwei, ZHANG Zhenxiang, MEI Yongxia, CHEN Suyan, LIN Beilei. Research progress of disease communication intervention for spouses with cancer [J]. Chinese Journal of Nursing, 2023, 58(18): 2288-2292.
[12]	LIU Cuiting, CHEN Liangying, CHEN Chunying, GAO Huiting, ZHOU Hongjuan, LIU Cuiping, QIU Lijuan. Latent profile analysis of reproductive concerns characteristics in young female breast cancer patients [J]. Chinese Journal of Nursing, 2023, 58(16): 1989-1995.
[13]	CHEN Liou, LIU Junqi, WANG Zhenlin, YANG Na, QI Sai, YING Bo. Nursing care of a patient with skull base osteonecrosis after radiotherapy for chordoma [J]. Chinese Journal of Nursing, 2023, 58(15): 1864-1868.
[14]	WANG Liying, DING Yan, ZHANG Yi, CHEN Yaqiong, XUE Mei, WANG Xia. The status and influencing factors of cancer-related cognitive impairment in patients with ovarian cancer [J]. Chinese Journal of Nursing, 2023, 58(14): 1726-1732.
[15]	ZHAO Xijuan, YANG Mingying, BIAN Yan, ZHANG Jiang, WU Guangliu, QIAN Yangfeng. Application of Health Recommender System in nursing care of cancer patients：a scoping review [J]. Chinese Journal of Nursing, 2023, 58(14): 1780-1786.